logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyPartnershipsAboutCareersContact Us
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.
    1. Home
    2. Indications
    3. Intensive Care Unit

    Medications for Intensive Care Unit

    FiltersReset Filters
    3 results
    • dexmedetomidine hydrochloride

      (Dexmedetomidine Hydrochloride)
      ENDO USA, Inc.
      Usage: Dexmedetomidine hydrochloride injection is indicated for sedation in mechanically ventilated adult ICU patients and for non-intubated adults during surgical or other procedures. It facilitates continuous sedation without the need for discontinuation prior to extubation, and has specific pediatric usage approved for another product.
    • dexmedetomidine hydrochloride in 0.9% sodium chloride

      (DEXMEDETOMIDINE HYDROCHLORIDE in 0.9% sodium chloride)
      Baxter Healthcare Corporation
      Usage: Dexmedetomidine hydrochloride in 0.9% sodium chloride injection is indicated for sedation in mechanically ventilated adult patients in intensive care and for non-intubated adult patients during surgical and other procedures. It can be used continuously during extubation without interruption. Pediatric use information exists but is not included in this product.
    • dexmedetomidine hydrochloride in sodium chloride

      (Dexmedetomidine Hydrochloride)
      Precision Dose, Inc.
      Usage: Dexmedetomidine HCl in 0.9% sodium chloride injection is indicated for sedation in mechanically ventilated adults in intensive care and for non-intubated adults undergoing surgical and other procedures. It can be administered continuously for up to 24 hours without needing to be discontinued before extubation.